Sort
21,453 grants matching “tuberculosis”
MACROPHAGES, DENDRITIC CELLS AND PATHOGENS
$1,388,080Weill Medical College Of Cornell Univ · P01 · FY2005 · AI
CIPRA-SA: Safeguard the household: comprehensive AIDS research: Extension
$1,386,629James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U19 · FY2010 · AI
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)
$1,386,598Stella Maria Hartinger · Universidad Peruana Cayetano Heredia · UH3 · FY2024 · HL
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment
$1,386,485Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2016 · AI
Genes/Pathways for Autophagy-dependent inhibition of Bacterial Infections
$1,386,338Ramnik J Xavier · Washington University · U19 · FY2017 · AI
Genomics of bacterial pathogens: host response, persistence and transmission
$1,385,087Ashlee Miriam Earl · Broad Institute, Inc. · U19 · FY2015 · AI
MACROPHAGES, DENDRITIC CELLS AND PATHOGENS
$1,384,909Carl F Nathan · Weill Medical Coll Of Cornell Univ · P01 · FY2006 · AI
TUBERCULOSIS ELIMINATION
$1,381,945Wilfred Rabi · Tennessee State Department Of Health · U52 · FY2013 · PS
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$1,380,842University Of Texas Sw Med Ctr/Dallas · U01 · FY2003 · AI
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
$1,378,282Jeanette Coffin · Midwest Research Institute · N01 · FY2018 · AI
SUPPORT MYCOBACTERIUM TUBERCULOSIS RESEARCH PROGRAMS
$1,377,468Baylor College Of Medicine · N01 · FY2000 · AO
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM
$1,376,656Nancy Baruch · Maryland State Department Of Health · U52 · FY2014 · PS
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$1,375,435Anna Bershteyn · New York University School Of Medicine · RF1 · FY2025 · MH
The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial
$1,375,182Jason Edward Farley · Johns Hopkins University · R01 · FY2025 · AI
TUBERCULOSIS SURVEILLANCE, PREVENTION AND CONTROL/ELIMINATION COOPERATIVE AGREEME
$1,374,598James Scioneaux · Louisiana State Office Of Public Health · U52 · FY2010 · PS
GHESKIO HIV Clinical Trial Unit
$1,374,213Jean William Pape · Gheskio Center · UM1 · FY2013 · AI
Aerobiology
$1,373,806Igor Kramnik · Boston University Medical Campus · UC7 · FY2012 · AI
Analysis of Host-Pathogen Interactions
$1,372,656Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,372,448Nancy Baruch · Maryland State Department Of Health · U52 · FY2006 · PS
Tulane National Primate Research Center
$1,372,003Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2009 · RR
PS05-003 TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,371,538Sharon Hensley · Tennessee State Department Of Health · U52 · FY2007 · PS
Membrane Protein Structural Genomics: M. tuberculosis
$1,370,609Florida State University · P01 · FY2002 · GM
Machine learning and artificial intelligence research for clinical medical image processing
$1,370,493Sameer Antani · National Library Of Medicine · ZIA · FY2024 · LM
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,369,582Mark Fredric Cotton · Stellenbosch University · UM1 · FY2014 · AI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,368,144Shabaana A. Khader · University Of Chicago · R01 · FY2024 · AI